UBS Group
TROVU

UBS Group’s TrovaGene, Inc. - Unit TROVU Stock Holding History

UBS Group’s Portfolio TROVU Stock Details TROVU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-240
Closed -$1K – 8415
2017
Q1 		$1K Buy
+240
New +$1K ﹤0.01% 7561

UBS Group's TROVU Position: Q2 2017 in Review

UBS Group sold out of TrovaGene, Inc. - Unit (TROVU) in Q2 2017, closing a stake of 240 shares — an estimated $1K sold.

UBS Group first reported a position in TROVU in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 0 funds tracked by Wall St. Rank hold TROVU as of Q2 2017.

  • UBS Group reported no remaining TrovaGene, Inc. - Unit position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 240 TrovaGene, Inc. - Unit shares in Q2 2017, an estimated $1K.
  • UBS Group first reported a position in TrovaGene, Inc. - Unit in Q1 2017 and held it in 1 quarter.
  • UBS Group's TrovaGene, Inc. - Unit position peaked at $1K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held TrovaGene, Inc. - Unit as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.